Back to Search
NIDA FELLER, MD
MD
Emergency Medicine Physician
NPI: 1366937575IndividualAccepts Medicare
Specialties, Licenses & Credentials
Emergency Medicine PhysicianPrimary
Emergency Medicine
Code: 207P00000X
125073370(IL)
CMS Specialties
PrimaryEMERGENCY MEDICINE
Education
SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE
Class of 2018
Research & Publications (19)
Interleukin-2 receptor alpha-chain (CD25) expression on leukaemic blasts is predictive for outcome and level of residual disease in AML.
PMID 19321337·Eur J Cancer·2009
8-other
Correlation of minimal residual disease cell frequency with molecular genotype in patients with acute myeloid leukemia.
PMID 19042917·Haematologica·2009
8-other
Positive selection for CD90 as a purging option in acute myeloid leukemia stem cell transplants.
PMID 18061946·Cytometry B Clin Cytom·2008
8-other
The novel AML stem cell associated antigen CLL-1 aids in discrimination between normal and leukemic stem cells.
PMID 17609428·Blood·2007
7-preclinical
Aberrant marker expression patterns on the CD34+CD38- stem cell compartment in acute myeloid leukemia allows to distinguish the malignant from the normal stem cell compartment both at diagnosis and in remission.
PMID 17525725·Leukemia·2007
4-observational
High stem cell frequency in acute myeloid leukemia at diagnosis predicts high minimal residual disease and poor survival.
PMID 16166428·Clin Cancer Res·2005
8-other
Immunologic purging of autologous peripheral blood stem cell products based on CD34 and CD133 expression can be effectively and safely applied in half of the acute myeloid leukemia patients.
PMID 16000576·Clin Cancer Res·2005
3-trial
Minimal residual disease in acute myeloid leukemia is predicted by an apoptosis-resistant protein profile at diagnosis.
PMID 15814631·Clin Cancer Res·2005
8-other
Purging of peripheral blood stem cell transplants in AML: a predictive model based on minimal residual disease burden.
PMID 15661405·Exp Hematol·2005
3-trial
C-type lectin-like molecule-1: a novel myeloid cell surface marker associated with acute myeloid leukemia.
PMID 15548716·Cancer Res·2004
8-other
MRD parameters using immunophenotypic detection methods are highly reliable in predicting survival in acute myeloid leukaemia.
PMID 15201848·Leukemia·2004
8-other
Minimal residual disease cells in AML patients have an apoptosis-sensitive protein profile.
PMID 14762445·Leukemia·2004
8-other
Assessment of the normal or leukemic nature of CD34+ cells in acute myeloid leukemia with low percentages of CD34 cells.
PMID 12969806·Haematologica·2003
4-observational
Minimal residual disease in acute myeloid leukemia is predicted by P-glycoprotein activity but not by multidrug resistance protein activity at diagnosis.
PMID 12886261·Leukemia·2003
8-other
Multiparameter flow cytometric quantification of apoptosis-related protein expression.
PMID 12682638·Leukemia·2003
8-other
A flow cytometric method to detect apoptosis-related protein expression in minimal residual disease in acute myeloid leukemia.
PMID 12682637·Leukemia·2003
4-observational
Function of the ABC transporters, P-glycoprotein, multidrug resistance protein and breast cancer resistance protein, in minimal residual disease in acute myeloid leukemia.
PMID 12604403·Haematologica·2003
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 701 N 1ST ST STE D220
SPRINGFIELD, IL 62702 - Phone
- (217) 545-3518
Quick Facts
- NPI
- 1366937575
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 2
- Years in Practice
- 8
- Publications
- 19
Are you this provider?
Claim Your Profile